The first paragraph summed it well - drastic price reduction would enable more breast cancer patients with HER2-positive to be treated with trastuzumab. Trastuzumab treatment is heavily subsidised for patients who fits certain strict criterias in government hospitals. For these patients, this news won't affect them. Who will it benefit then? Besides adhering to KKM … Continue reading Good News for Breast Cancer Patients (with HER2-positive)
Points Across The study published in reputable The Lancet Oncology journal emphasised on proper selection of cancer patients for chemotherapy treatment, especially patients who are old or have poor performance status. importance of mortality review in order to improve clinical decision making (identifying patients who does not benefit or not suitable for chemotherapy treatment, eg. … Continue reading News: Chemotherapy Kill Cancer Patients. Not Cancer?